Why the study?
Does the CHA2DS2-VASc score accurately stratify stroke risk in Asian patients with atrial fibrillation?
Population
5,855 oral anticoagulant-naive nonvalvular atrial fibrillation patients aged ≥20 years from the Korea…
Design
Cohort
Follow-up
Enrolled 2002-2008 and followed up until December 2013
Authors
Loading...
May warrant ethnicity-specific CHA2DS2-VASc thresholds in AF; hypothesis-generating for prospective validation before practice change.
Does the CHA2DS2-VASc score accurately stratify stroke risk in Asian patients with atrial fibrillation?
The CHA2DS2-VASc score effectively identifies truly low-risk Asian patients with atrial fibrillation, validating its use in this population despite some differences in individual risk factor weights such as female sex.
Kim et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: